Maulana Azad Medical College

Aethlon Medical Announces Fiscal Third Quarter Financial Results and Provides Corporate Update

Retrieved on: 
Mercredi, février 14, 2024
Viral, Internet, Call, MAMC, Blood, Interest, Exosome, Marketing, Maulana Azad Medical College, Metastasis, Organ transplantation, Ethics, Interim, Intensive care medicine, COVID-19, Consolidated, DCGI, Virus, Patient, Clinical trial, Infection, Plasma, Insurance, Research, Travel, Cancer, Pharmaceutical industry

SAN DIEGO, Feb. 14, 2024 /PRNewswire/ -- Aethlon Medical, Inc. (Nasdaq: AEMD), a medical therapeutic company focused on developing products to treat cancer and life-threatening infectious diseases, today reported financial results for its fiscal third quarter ended December 31, 2023 and provided an update on recent developments. 

Key Points: 
  • ET
    SAN DIEGO, Feb. 14, 2024 /PRNewswire/ -- Aethlon Medical, Inc. (Nasdaq: AEMD), a medical therapeutic company focused on developing products to treat cancer and life-threatening infectious diseases, today reported financial results for its fiscal third quarter ended December 31, 2023 and provided an update on recent developments.
  • "While our research and development team has started to quantify our internal data, the results, to date, are inconclusive.
  • Financial Results for the Third Quarter Ended December 31, 2023
    As of December 31, 2023, Aethlon Medical had a cash balance of approximately $8.0 million.
  • ET to review its financial results for its fiscal third quarter ended December 31, 2023 and recent corporate developments.

Independence Blue Cross announces new, expanded role for Dr. Reetika Kumar, FACP

Retrieved on: 
Lundi, janvier 29, 2024
Hope, Optum, Internal medicine, Health, IBX, Partnership, FACP, Pharmacy, Maulana Azad Medical College, COVID-19, POWER, Human, Organization, Vaccine, Independence Blue Cross, Nursing

PHILADELPHIA, Jan. 29, 2024 /PRNewswire/ -- Independence Blue Cross (IBX) announced a new and expanded role for Dr. Reetika Kumar, FACP, serving the organization as vice president, Market Clinical Solutions and Pharmacy Services.

Key Points: 
  • PHILADELPHIA, Jan. 29, 2024 /PRNewswire/ -- Independence Blue Cross (IBX) announced a new and expanded role for Dr. Reetika Kumar, FACP, serving the organization as vice president, Market Clinical Solutions and Pharmacy Services.
  • Within this increased role, Dr. Kumar will manage full accountability for pharmacy profit and loss, pharmacy clinical programs, and pharmacy sales and product development.
  • Dr. Kumar will continue to serve as the clinical face of the organization's sales and marketing activities for health, pharmacy, and ancillary products.
  • "Reetika is a compassionate and respected physician who has made a tremendous impact since joining IBX.

Aethlon Medical Announces Fiscal First Quarter Financial Results and Provides Corporate Update

Retrieved on: 
Jeudi, août 10, 2023
Call, Infection, Insurance, Maintenance, Maulana Azad Medical College, Hospital, Private law, Internet, PBC, Perfusion, MAMC, COVID-19, Clinical trial, Cancer, Research, NAMSA, Trial of the century, Accounting, Interest, Data monitoring committee, Transplant, Patient, Blood, Viral, Depreciation, Exosome, Consolidated, ICU, Metastasis, Safety, Pharmaceutical industry, Health insurance, Conference

SAN DIEGO, Aug. 10, 2023 /PRNewswire/ -- Aethlon Medical, Inc. (Nasdaq: AEMD), a medical therapeutic company focused on developing products to treat cancer and life threatening infectious diseases, today reported financial results for its fiscal first quarter ended June 30, 2023 and provided an update on recent developments. 

Key Points: 
  • ET
    SAN DIEGO, Aug. 10, 2023 /PRNewswire/ -- Aethlon Medical, Inc. (Nasdaq: AEMD), a medical therapeutic company focused on developing products to treat cancer and life threatening infectious diseases, today reported financial results for its fiscal first quarter ended June 30, 2023 and provided an update on recent developments.
  • Aethlon Medical believes that the data generated from this trial will help inform the design of future oncology efficacy trials of the company's Hemopurifier.
  • Financial Results for the First Quarter Ended June 30, 2023
    As of June 30, 2023, Aethlon Medical had a cash balance of approximately $12.9 million.
  • ET to review its financial results for its first quarter ended June 30, 2023 and recent corporate developments.

Aethlon Medical Receives Ethics Board Approval to Add Second Site to its Ongoing Clinical Trial of its Hemopurifier® to Treat Severe COVID-19 in India

Retrieved on: 
Lundi, mai 22, 2023
Infection, Maulana Azad Medical College, University, Hospital, SARS-CoV-2, ERB, MAMC, COVID-19, Clinical trial, Faculty of Law, University of Delhi, Cancer, Patient, SAN, ICU, Pharmaceutical industry

MAMC was established in 1958 and is located in New Delhi, India.

Key Points: 
  • MAMC was established in 1958 and is located in New Delhi, India.
  • MAMC is affiliated with the University of Delhi and is operated by the Delhi government.
  • The addition of MAMC as a second high quality clinical site may improve our enrollment of patients who go on to require ICU care for severe infection," commented Steven LaRosa, M.D., Chief Medical Officer of Aethlon Medical.
  • The initial site for the ongoing trial is Medanta Medicity Hospital in Gurgaon, India, and currently remains open for enrollment, with one patient treated to date.